This report also showed that Copine 3 expression is increased significantly in metastatic prostate cancer compared with normal prostate and nonmetastatic tumors and in ovarian endometrioid carcinomas compared with normal ovarian tissues. The gene discussed is CPNE3; the disease is ovarian endometrioid carcinoma.